Galera Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€3.27M - Gross profit
-€3.27M - SG&A expenses
€6.87M - R&D expenses
€349.71K - EBITDA
-€11.89M - D&A
-€136.47K - EBIT
-€12.34M - Interest expenses
€0.00 - EBT
-€11.41M - Tax expenses
-€143.91K - Net income
-€11.24M
Cash flow statement
- Net deferred tax
-€346.30K - Non-cash items
€4.97M - Changes in working capital
-€1.24M - Operating cash flow
€4.41M - Capex
€0.00 - Other investing cash flow
-€39.24K - Net investing cash flow
-€39.24K - Total cash dividends paid
€0.00 - Issuance of common stock
€2.44M - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€2.44M - Foreign exchange effects
€0.00 - Net change in cash
-€4.71M - Cash at end of period
€4.46M - Free cash flow
€4.41M
Balance sheet
- Cash and cash equivalents
€4.46M - Cash and short-term investments
€4.46M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€611.57K - Total current assets
€5.07M - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€86.15K - Total non-current assets
€86.15K - Total assets
€5.16M - Accounts payable
€172.30K - Short-term debt
€0.00 - Other current liabilities
€123.68K - Total current liabilities
€295.97K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€131.05M - Total non-current liabilities
€131.05M - Total liabilities
€131.35M - Common stock
€63.97K - Retained earnings
-€391.53M - Other equity
€0.00 - Total equity
-€126.19M - Total liabilities and shareholders' equity
€5.16M
Company information
- Market capitalization
€1.83M - Employees
3 - Enterprise Value
-€4.61M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
8.9% Much better than peer group: -52.0% - ROA
-
-217.9% Much worse than peer group: -46.8% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
240.3% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€3.75M